Does NIVOLUMAB Cause Facial paralysis? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Facial paralysis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.2% of all adverse event reports for NIVOLUMAB.
171
Reports of Facial paralysis with NIVOLUMAB
0.2%
of all NIVOLUMAB reports
15
Deaths
79
Hospitalizations
How Dangerous Is Facial paralysis From NIVOLUMAB?
Of the 171 reports, 15 (8.8%) resulted in death, 79 (46.2%) required hospitalization, and 5 (2.9%) were considered life-threatening.
Is Facial paralysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Facial paralysis?
ADALIMUMAB (382)
ONABOTULINUMTOXINA (305)
METHOTREXATE (304)
ETANERCEPT (169)
RITUXIMAB (151)
SECUKINUMAB (140)
PREDNISONE (139)
ASPIRIN (127)
FINGOLIMOD (121)
IPILIMUMAB (116)
Which NIVOLUMAB Alternatives Have Lower Facial paralysis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE